Designing an Epitope-Driven Vaccine for a “Stealth Virus” an H7N9 Case Study: Recorded by DNAvaccine.com, December 6th, 2013, presented by Dr. Annie De Groot, MD, CEO and CSO of EpiVax, Inc.
The online recording of Dr. De Groot’s presentation: Designing an Epitope-Driven Vaccine for a “Stealth Virus” an H7N9 Case Study can be viewed in the webinar tab found on our homepage. To view this and other archived webinars simply click on the following link: https://www.dnavaccine.com/resources/. For more EpiVax videos, please see the the EpiVax YouTube Page.
Webinar Overview: Annie De Groot, of EpiVax, discusses some of EpiVax’s current vaccine work. Dr. De Groot also discusses the use of immunoinformatics tools in vaccine designs, mechanisms of action studies, and efficacy evaluations with a focus on the H7N9 virus and the iVAX system. The presentation explores how emerging and re-emerging infectious diseases represent a significant challenge for next-generation vaccine design and bioterror preparedness. EpiVax has designed vaccines using a proprietary suite of online immunoinformatics tools for accelerated design of genome-derived, epitope-driven vaccines.
Trackbacks/Pingbacks